Key Details
The company received trading approval from both National Stock Exchange of India Limited (NSE) and BSE Limited for 2,69,402 equity shares of ₹10 each allotted pursuant to conversion of warrants issued on preferential basis.
Approval Details:
- NSE approval via letter no. NSE/LIST/55629 dated June 11, 2026
- BSE approval via letter no. LOD/PREF/SV/247/2026-2027 dated June 11, 2026
- Shares listed and admitted to dealings on both exchanges from June 12, 2026
Capital Structure Impact:
Upon receipt of trading approvals, the listed capital of the company became ₹10,05,33,920 (1,00,53,392 fully paid equity shares of ₹10 each).
Share Details:
- Total shares: 2,69,402 equity shares of ₹10 each
- Distinctive numbers: 9783991 to 10053392
- Issued at a premium of ₹542.00 per share
Lock-in Period Details:
- 2,63,602 shares (distinctive numbers 9783991 to 10047592) locked in until December 14, 2027
- 5,800 shares (distinctive numbers 10047593 to 10053392) locked in until December 14, 2026
- Total locked shares: 2,69,402
Regulatory References:
- Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Additional disclosures provided as required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024
Documentation:
The company has enclosed the trading approval letters received from both NSE and BSE with this disclosure.
Hemaxi Pawar, Company Secretary (Membership No.: A52581)
Company Information:
Diamines and Chemicals Limited (CIN No. L24110GJ1976PLC002905)
Plot No. 13 P.C.C. Area, P.O. Petrochemicals, Dist. Vadodara 391346, Gujarat (India)